161 related articles for article (PubMed ID: 23803755)
1. Mechanisms and prevention of alloimmunization in pregnancy.
Kjeldsen-Kragh J; Skogen B
Obstet Gynecol Surv; 2013 Jul; 68(7):526-32. PubMed ID: 23803755
[TBL] [Abstract][Full Text] [Related]
2. Towards a prophylactic treatment of HPA-related foetal and neonatal alloimmune thrombocytopenia.
Kjeldsen-Kragh J; Ni H; Skogen B
Curr Opin Hematol; 2012 Nov; 19(6):469-74. PubMed ID: 22954726
[TBL] [Abstract][Full Text] [Related]
3. Fetal and Neonatal Alloimmune Thrombocytopenia-New Prospects for Fetal Risk Assessment of HPA-1a-Negative Pregnant Women.
Kjeldsen-Kragh J; Bengtsson J
Transfus Med Rev; 2020 Oct; 34(4):270-276. PubMed ID: 33039264
[TBL] [Abstract][Full Text] [Related]
4. Strategies to develop a prophylaxis for the prevention of HPA-1a immunization and fetal and neonatal alloimmune thrombocytopenia.
Kjær M; Geisen C; Akkök ÇA; Wikman A; Sachs U; Bussel JB; Nielsen K; Walles K; Curtis BR; Vidarsson G; Järås K; Skogen B
Transfus Apher Sci; 2020 Feb; 59(1):102712. PubMed ID: 31948915
[TBL] [Abstract][Full Text] [Related]
5. Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model.
Tiller H; Killie MK; Chen P; Eksteen M; Husebekk A; Skogen B; Kjeldsen-Kragh J; Ni H
Transfusion; 2012 Jul; 52(7):1446-57. PubMed ID: 22251227
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics of human platelet antigen (HPA)-1a and HPA-5b alloimmunised pregnancies and the association between platelet HPA-5b antibodies and symptomatic fetal neonatal alloimmune thrombocytopenia.
de Vos TW; Porcelijn L; Hofstede-van Egmond S; Pajkrt E; Oepkes D; Lopriore E; van der Schoot CE; Winkelhorst D; de Haas M
Br J Haematol; 2021 Nov; 195(4):595-603. PubMed ID: 34402048
[TBL] [Abstract][Full Text] [Related]
7. Anti-Human Platelet Antigen-1a Immunoglobulin G Preparation Intended to Prevent Fetal and Neonatal Alloimmune Thrombocytopenia.
Weng YJ; Husebekk A; Skogen B; Kjaer M; Lin LT; Burnouf T
PLoS One; 2016; 11(9):e0162973. PubMed ID: 27627660
[TBL] [Abstract][Full Text] [Related]
8. An HPA-1a-positive platelet-depleting agent for prevention of fetal and neonatal alloimmune thrombocytopenia: a randomized, single-blind, placebo-controlled, single-center, phase 1/2 proof-of-concept study.
Geisen C; Kjaer M; Fleck E; Skogen B; Armstrong R; Behrens F; Bhagwagar Z; Braeuninger S; Mortberg A; Olsen KJ; Gastón Schäfer SM; Walter C; Seifried E; Wikman A; Kjeldsen-Kragh J; Koehm M
J Thromb Haemost; 2023 Apr; 21(4):838-849. PubMed ID: 36696185
[TBL] [Abstract][Full Text] [Related]
9. Fetal/Neonatal Alloimmune Thrombocytopenia: Pathogenesis, Diagnostics and Prevention.
Brojer E; Husebekk A; Dębska M; Uhrynowska M; Guz K; Orzińska A; Dębski R; Maślanka K
Arch Immunol Ther Exp (Warsz); 2016 Aug; 64(4):279-90. PubMed ID: 26564154
[TBL] [Abstract][Full Text] [Related]
10. Prevention of Fetal/Neonatal Alloimmune Thrombocytopenia in Mice: Biochemical and Cell Biological Characterization of Isoforms of a Human Monoclonal Antibody.
Mørtberg TV; Zhi H; Vidarsson G; Foss S; Lissenberg-Thunnissen S; Wuhrer M; Michaelsen TE; Skogen B; Stuge TB; Andersen JT; Newman PJ; Ahlen MT
Immunohorizons; 2022 Jan; 6(1):90-103. PubMed ID: 35074850
[TBL] [Abstract][Full Text] [Related]
11. [PREVFNAIT prevention of foetal/neonatal alloimmune thrombocytopenia (FNAIT) in Polish foetuses and newborns--the PREVFNAIT program].
Uhrynowska ME; Dębska M; Guz K; Orzińska A; Wróbel A; Maślanka K; Dębski R; Brojer E
Ginekol Pol; 2015 Jan; 86(1):62-6. PubMed ID: 25775877
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic administration of HPA-1a-specific antibodies prevents fetal/neonatal alloimmune thrombocytopenia in mice.
Zhi H; Sheridan D; Newman DK; Newman PJ
Blood; 2022 Nov; 140(20):2146-2153. PubMed ID: 35881848
[TBL] [Abstract][Full Text] [Related]
13. Fetal and neonatal alloimmune thrombocytopenia: predictive factors of intracranial hemorrhage.
Delbos F; Bertrand G; Croisille L; Ansart-Pirenne H; Bierling P; Kaplan C
Transfusion; 2016 Jan; 56(1):59-66; quiz 58. PubMed ID: 26469867
[TBL] [Abstract][Full Text] [Related]
14. Maternal HPA-1a antibody level and its role in predicting the severity of Fetal/Neonatal Alloimmune Thrombocytopenia: a systematic review.
Kjaer M; Bertrand G; Bakchoul T; Massey E; Baker JM; Lieberman L; Tanael S; Greinacher A; Murphy MF; Arnold DM; Baidya S; Bussel J; Hume H; Kaplan C; Oepkes D; Ryan G; Savoia H; Shehata N; Kjeldsen-Kragh J;
Vox Sang; 2019 Jan; 114(1):79-94. PubMed ID: 30565711
[TBL] [Abstract][Full Text] [Related]
15. Human platelet antigen (HPA)-1a peptides do not reliably suppress anti-HPA-1a responses using a humanized severe combined immunodeficiency (SCID) mouse model.
Jackson DJ; Eastlake JL; Kumpel BM
Clin Exp Immunol; 2014 Apr; 176(1):23-36. PubMed ID: 24261689
[TBL] [Abstract][Full Text] [Related]
16. Maternal anti-platelet β3 integrins impair angiogenesis and cause intracranial hemorrhage.
Yougbaré I; Lang S; Yang H; Chen P; Zhao X; Tai WS; Zdravic D; Vadasz B; Li C; Piran S; Marshall A; Zhu G; Tiller H; Killie MK; Boyd S; Leong-Poi H; Wen XY; Skogen B; Adamson SL; Freedman J; Ni H
J Clin Invest; 2015 Apr; 125(4):1545-56. PubMed ID: 25774504
[TBL] [Abstract][Full Text] [Related]
17. Prenatal Management of Pregnancies at Risk of Fetal Neonatal Alloimmune Thrombocytopenia (FNAIT): Scientific Impact Paper No. 61.
Regan F; Lees CC; Jones B; Nicolaides KH; Wimalasundera RC; Mijovic A;
BJOG; 2019 Sep; 126(10):e173-e185. PubMed ID: 30968555
[TBL] [Abstract][Full Text] [Related]
18. New developments in fetal and neonatal alloimmune thrombocytopenia.
Bussel JB; Vander Haar EL; Berkowitz RL
Am J Obstet Gynecol; 2021 Aug; 225(2):120-127. PubMed ID: 33839095
[TBL] [Abstract][Full Text] [Related]
19. The prevalence of HPA-1a alloimmunization and the potential risk of FNAIT depend on both the DRB3*01:01 allele and associated DR-DQ haplotypes.
Ahlen MT; Heide G; Husebekk A; Skogen B; Kjeldsen-Kragh J; Stuge TB
Scand J Immunol; 2020 Jul; 92(1):e12890. PubMed ID: 32299122
[TBL] [Abstract][Full Text] [Related]
20. Fetal and neonatal alloimmune thrombocytopenia - The Norwegian management model.
Tiller H; Ahlen MT; Akkök ÇA; Husebekk A
Transfus Apher Sci; 2020 Feb; 59(1):102711. PubMed ID: 31911047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
